Biotech

All Articles

Ascendis' dwarfism medication favorites in period 3, endangers BioMarin

.Ascendis Pharma has become a possible risk to BioMarin's Voxzogo, stating phase 3 development ailme...

Despite ph. 3 miss out on, Alkeus views road ahead of time for eye disease property

.Though Alkeus Pharmaceuticals' oral eye ailment property neglected to significantly minimize geogra...

Kairos goes social along with $6M IPO to money trials of cancer drug

.Along with a triad of biotechs hitting the Nasdaq on Friday, it was very easy to skip a smaller-sca...

Vaccine and also Keytruda combo efficient in squamous tissue carcinoma

.Invulnerable gate inhibitors are actually the superheroes of cancer treatment. Medicines like Brist...

Cue Biopharma queues up J&ampJ veterinarian as CBO-- Chutes &amp Ladders

.Welcome to today's Chutes &amp Ladders, our summary of significant leadership hirings, firings and ...

Regeneron's Opdualag opponent shows 57% response fee

.Regeneron is actually back along with long-lasting follow-up for its own LAG-3 prevention and PD-1 ...

AstraZeneca posts information on in-house opponents to AbbVie, Pfizer ADCs

.AstraZeneca has shared a very early check out the functionality of its internal antibody-drug conju...

iTeos- GSK's TIGIT superstar reveals relevant renovation

.After announcing a stage 3 launch based on positive midstage results, iTeos and GSK are eventually ...

More collective FDA can increase uncommon health condition R&ampD: file

.The FDA must be actually much more open as well as joint to unleash a surge in approvals of uncommo...

Zenas, MBX, Bicara scalp to Nasdaq in scorching day for biotech IPOs

.It is actually an abnormally busy Friday for biotech IPOs, with Zenas BioPharma, MBX and also Bicar...